Rogers J A, Anderson K E
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.
Crit Rev Ther Drug Carrier Syst. 1998;15(5):421-80.
Oral liposome drug delivery has been the subject of much cynicism. Results have been quite variable and, for the most part, have not been predicated on specific objectives that would lead to success. Prerequisites are stability in the gastrointestinal environment and binding to specific sites. Transport via paracellular and transcellular routes from normal epithelial tissue or Peyer's patches leads to different outcomes of drug delivery and immunization, respectively. Polymerized, microencapsulated, and polymer-coated liposomes have all increased the potential of oral liposomes. Using targeted liposomes and a greater understanding of their cellular processing will ultimately lead to effective therapies from oral liposomes.
口服脂质体给药一直备受质疑。结果差异很大,而且在很大程度上,这些结果并非基于能够带来成功的特定目标。前提条件是在胃肠道环境中稳定并与特定部位结合。通过正常上皮组织或派尔集合淋巴结的细胞旁和跨细胞途径转运分别导致不同的药物递送和免疫结果。聚合脂质体、微囊化脂质体和聚合物包被脂质体都增加了口服脂质体的潜力。使用靶向脂质体并更深入地了解它们的细胞处理过程最终将带来口服脂质体的有效疗法。